PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway.
Ontology highlight
ABSTRACT: Gastric cancer is a high molecular heterogeneous disease with a poor prognosis. Although gastric cancer is a hot area of medical research, the mechanism of gastric cancer occurrence and development is still unclear. New strategies for treating gastric cancer need to be further explored. Protein tyrosine phosphatases play vital roles in cancer. A growing stream of studies shows that strategies or inhibitors targeting protein tyrosine phosphatases have been developed. PTPN14 belongs to the protein tyrosine phosphatase subfamily. As an inert phosphatase, PTPN14 has very poor activity and mainly functions as a binding protein through its FERM (four-point-one, ezrin, radixin, and moesin) domain or PPxY motif. The online database indicated that PTPN14 may be a poor prognostic factor for gastric
SUBMITTER: Li H
PROVIDER: S-EPMC10006225 | biostudies-literature | 2023 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA